KSK Diagnostics Overview
- Founded
- 2014
- Status
- Out of Business
- Latest Deal Type
- Out of Business
KSK Diagnostics General Information
Description
Developer of molecular point-of-care diagnostic assays designed to diagnose infectious diseases and cancer. The company's assays use isothermal amplification technology for patient-oriented diagnostics and are also suited to quickly clarify issues related to tumour diagnostics, enabling doctors to make a diagnosis after 30 minutes and coordinate the treatment.
Contact Information
Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Diagnostic Equipment
Primary Office
- Tempowerkring 1
- 21079 Hamburg
- Germany
+49 040 00000000
KSK Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Jan-2019 | Completed | Out of Business | |||
| 2. Early Stage VC (Series A) | 24-Apr-2017 | Completed | Startup | |||
| 1. Grant | $167K | Completed | Startup |
KSK Diagnostics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Stefan Kulick | Co-Founder & Managing Director | ||
| Guido Krupp | Co-Founder | ||
| Peter Scheinert | Co-Founder |